C B PHARMA ACQUISITION CORP's ticker is CNLMW and the CUSIP is G2029P118. A total of 4 filers reported holding C B PHARMA ACQUISITION CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $20,000 | -53.5% | 239,775 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $43,000 | -46.2% | 239,775 | -31.5% | 0.00% | -60.0% |
| Q3 2015 | $80,000 | -43.7% | 350,000 | 0.0% | 0.01% | -16.7% |
| Q2 2015 | $142,000 | +69.0% | 350,000 | 0.0% | 0.01% | +20.0% |
| Q1 2015 | $84,000 | – | 350,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bulldog Investors, LLP | 75,000 | $6,000 | 0.00% |
| Polar Asset Management Partners Inc. | 239,775 | $20,000 | 0.00% |
| GLAZER CAPITAL, LLC | 21,824 | $2,000 | 0.00% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 350,000 | $23,000 | 0.00% |